Advertisement

week in cancer news

  • April 22: The Week in Cancer News

    Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.

    by Kevin McLaughlin

  • April 15: The Week in Cancer News

    Trial of ‘practice-changing’ immunotherapy yields positive results for lung cancer patients, and CAR T-cell therapy shows effectiveness in targeting certain solid tumors.

    by Thomas Celona

  • April 8: The Week in Cancer News

    CAR T-cell therapy approved for relapsed large B-cell lymphoma, and screening catches lung cancer earlier, although disparities persist.

    by Kevin McLaughlin

  • April 1: The Week in Cancer News

    Chemo brain may provide clues for long-haul COVID-19, and researchers analyze relationship between obesity and cancer.

    by Marci A. Landsmann

  • March 25: The Week in Cancer News

    FDA approves combination immunotherapy for treating melanoma, and screening tool improves pancreatic cancer detection.

    by Kevin McLaughlin

  • March 18: The Week in Cancer News

    Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast cancer for people with inherited BRCA mutations.

    by Eric Fitzsimmons

  • March 11: The Week in Cancer News

    FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.

    by Kevin McLaughlin

  • March 4: The Week in Cancer News

    Study finds lower rates of screening-related breast cancer overdiagnosis and children with cancer in Ukraine continue treatment in hospital’s basement.

    by Marci A. Landsmann

  • February 25: The Week in Cancer News

    Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.

    by Eric Fitzsimmons

  • February 18: The Week in Cancer News

    Aspirin is ineffective in preventing breast cancer recurrence, and immunotherapy holds promise for some patients with advanced anal cancer.

    by Kevin McLaughlin

Advertisement